152 related articles for article (PubMed ID: 38332225)
61. [Tumour-stroma interactions in urothelial cancer].
Hatina J; Kripnerová M; Tuková J; Šrámek J; Dvořák P; Pešta M; Dobrá J; Babuška V; Racek J; Sobol M; Philimonenko A; Hozák P; Czuba Z; Schulz WA; Strell C; Grimm S; Jennek S; Friedrich KH
Urologe A; 2015 Apr; 54(4):516-25. PubMed ID: 25895564
[TBL] [Abstract][Full Text] [Related]
62. Both cancerous miR-21 and stromal miR-21 in urothelial carcinoma are related to tumour progression.
Ohno R; Uozaki H; Kikuchi Y; Kumagai A; Aso T; Watanabe M; Watabe S; Muto S; Yamaguchi R
Histopathology; 2016 Dec; 69(6):993-999. PubMed ID: 27383043
[TBL] [Abstract][Full Text] [Related]
63. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
[TBL] [Abstract][Full Text] [Related]
64. Clinicopathologic Features of Noninvasive Inverted Urothelial Papillary Tumor.
Liu Z; Wei S; Tang J
Am J Clin Oncol; 2023 Sep; 46(9):409-413. PubMed ID: 37370208
[TBL] [Abstract][Full Text] [Related]
65. Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
Brait M; Munari E; LeBron C; Noordhuis MG; Begum S; Michailidi C; Gonzalez-Roibon N; Maldonado L; Sen T; Guerrero-Preston R; Cope L; Parrella P; Fazio VM; Ha PK; Netto GJ; Sidransky D; Hoque MO
Cell Cycle; 2013 Apr; 12(7):1058-70. PubMed ID: 23435205
[TBL] [Abstract][Full Text] [Related]
66. Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma.
Miron B; Geynisman DM
Eur Urol; 2022 Oct; 82(4):374-376. PubMed ID: 35752503
[No Abstract] [Full Text] [Related]
67. [Drug approval: Enfortumab vedotin-advanced urothelial carcinoma (which have previously received platinum-containing chemotherapy and immunotherapy)].
Matte P; Campedel L
Bull Cancer; 2022; 109(7-8):738-740. PubMed ID: 35606195
[No Abstract] [Full Text] [Related]
68. TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.
Liang PI; Wei YC; Chen HD; Ma YC; Ke HL; Chien CC; Chuang HW
Kaohsiung J Med Sci; 2024 Mar; 40(3):269-279. PubMed ID: 38180299
[TBL] [Abstract][Full Text] [Related]
69. Bladder cancer: translating molecular genetic insights into clinical practice.
Cheng L; Zhang S; MacLennan GT; Williamson SR; Lopez-Beltran A; Montironi R
Hum Pathol; 2011 Apr; 42(4):455-81. PubMed ID: 21106220
[TBL] [Abstract][Full Text] [Related]
70. Emerging drugs for urothelial (bladder) cancer.
Cumberbatch K; He T; Thorogood Z; Gartrell BA
Expert Opin Emerg Drugs; 2017 Jun; 22(2):149-164. PubMed ID: 28556678
[TBL] [Abstract][Full Text] [Related]
71. [Plasmacytoid urothelial carcinoma of the urinary bladder. A study of 7 cases].
Gaafar A; Garmendia M; de Miguel E; Velasco V; Ugalde A; Bilbao FJ; de Petris G; López JI
Actas Urol Esp; 2008 Sep; 32(8):806-10. PubMed ID: 19013979
[TBL] [Abstract][Full Text] [Related]
72. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
73. H2O2 generation by bacillus Calmette-Guérin induces the cellular oxidative stress response required for bacillus Calmette-Guérin direct effects on urothelial carcinoma biology.
Shah G; Zielonka J; Chen F; Zhang G; Cao Y; Kalyanaraman B; See W
J Urol; 2014 Oct; 192(4):1238-48. PubMed ID: 24928267
[TBL] [Abstract][Full Text] [Related]
74. Urothelial carcinoma with abundant myxoid stroma.
Tavora F; Epstein JI
Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
[TBL] [Abstract][Full Text] [Related]
75. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
76. A new standard of care for advanced-stage urothelial carcinoma.
Sidaway P
Nat Rev Clin Oncol; 2024 May; 21(5):336. PubMed ID: 38509334
[No Abstract] [Full Text] [Related]
77. Re: Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
Tilgener C; Bedke J
Eur Urol; 2024 Jun; 85(6):591-592. PubMed ID: 38538421
[No Abstract] [Full Text] [Related]
78. A cribriform urothelial neoplasm of the renal pelvis: an adenoid cysticlike variant of inverted urothelial papilloma or florid ureteritis cystica?
Talmon GA; Khan A; Koerber R; Lele S; Johansson S
Arch Pathol Lab Med; 2010 Oct; 134(10):1557-9. PubMed ID: 20923313
[TBL] [Abstract][Full Text] [Related]
79. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
80. Single-cell atlases link macrophages and CD8
Liang Y; Tan Y; Guan B; Guo B; Xia M; Li J; Shi Y; Yu Z; Zhang Q; Liu D; Yang X; Hao J; Gong Y; Shakeel M; Zhou L; Ci W; Li X
Theranostics; 2022; 12(18):7745-7759. PubMed ID: 36451860
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]